Stay updated on Dupilumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record now presents details of the completed Phase 2 dupilumab study for chronic spontaneous urticaria, including its eligibility criteria, study locations, interventions, and outcome measures.
    Difference
    51%
    Check dated 2026-11-08T14:08:10.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The 403 Forbidden message and its Home link disappeared, leaving the ClinicalTrials.gov page shell without visible study-record content. The site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.6%
    Check dated 2026-11-01T15:37:19.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:25:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:01:18.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T21:50:22.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page, replacing the previously visible study record details for NCT03749135. This indicates the study information is temporarily inaccessible due to an access restriction or site issue.
    Difference
    18%
    Check dated 2026-09-20T20:40:42.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.